Key result
Analysis of 20,388 insured patients with chronic kidney disease revealed significant care deficiencies, including only 55.6% of stage 4 patients seeing a nephrologist within one year and 52% of those developing end-stage renal disease starting dialysis as inpatients.
Why the study?
Apparent deficiencies in the quality of care for chronic kidney disease patients, including medication use and nephrology referral, were not well characterized regionally.
Cross-Sectional (n=20,388)
This regional observational study highlights significant deficiencies in CKD care, including delayed nephrology referral, underuse of RAS blockers, inappropriate NSAID use, and lack of preparation for dialysis.
Answers are grounded in this paper and cite their sources.
Persistent CKD care gaps warrant quality improvement efforts; leaves open whether interventions enhance referral and dialysis planning.
BACKGROUND: The database of a major regional health insurer was employed to identify the number and frequency of covered patients with chronic kidney disease (CKD). We then examined the characteristics of their care as defined, in part, by the frequency of physician visits and specialty referral, the characteristics of laboratory testing and total costs as indices of the quality of care of the subject population. METHODS: This retrospective, cross-sectional study analyzed insurance claims, laboratory results and medication prescription data. Patients with two estimated glomerular filtration rate readings below 60 ml/min/1.73 m(2) (n = 20,388) were identified and classified by CKD stage. RESULTS: The prevalence of CKD stages 3a and above was 12 %. Vascular comorbidities were common with prevalence increasing steadily from stage 3a through stage 5. Only 55.6 % of stage 4 CKD patients had claims for nephrology visits within one year of their index date. Fifty-nine percent of patients had claims for renin-angiotensin system (RAS) blockers. Twenty-five percent of patients in stage 3a CKD filled a prescription for non-steroidal anti-inflammatory drugs. Fifty-two percent of patients who developed end-stage renal disease received their first dialysis treatment as inpatients. CONCLUSIONS: The pattern of medical practice observed highlights apparent deficiencies in the care of CKD patients including inappropriate medication use, delayed nephrology referral, and a lack of preparation for dialysis. This study shows the potential value of using large patient databases available through insurers to assess and likely improve regional CKD care.
No takes yet. Share an insight, caveat, or question.
Arora et al. (2015) conducted a cross-sectional in Chronic kidney disease (n=20,388). Quality of care for chronic kidney disease was evaluated on Quality of care indicators (nephrology visits, medication use, laboratory testing, preparation for dialysis). Analysis of 20,388 insured patients with chronic kidney disease revealed significant care deficiencies, including only 55.6% of stage 4 patients seeing a nephrologist within one year and 52% of those developing end-stage renal disease starting dialysis as inpatients.
Synapse has enriched 10 related papers. Consider them for comparative context: